Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the ...

Northwest Clinical Research Center specializes in clinical trials for new medications designed to slow or prevent diseases ...

The trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.

Peeples Cancer Institute at Hamilton Medical Center has expanded access to the latest in cancer research for patients in ...

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

Results from multiple clinical trials showed that Tagrisso demonstrated survival benefits in EGFR-mutated non-small cell lung ...

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Advanced treatment options and hair-loss clinics have continued to emerge — and researchers are making progress on finding ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...

Among successful revascularizations, there was a hint of better outcomes compared with OMT, but the data need confirmation.

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, ...